E-cadherin/Aurora A kinase inhibitor synthetic lethality in breast cancer

Invasive lobular breast carcinoma (ILC) is defined by loss of the adhesion protein E-cadherin. Using a cancer histology-focused analysis of large-scale drug sensitivity screens, we identify inhibition of the kinase Aurora A as a penetrant synthetic lethal interaction with E-cadherin loss. Combining isogenic cell models, quantitative proteomics, live-cell imaging, patient-derived tumor organoids, and orthotopic xenografts from patients with heavily pre-treated metastatic ILC (mILC), we show that E-cadherin loss alters catenin/Rho/ROCK signaling and imposes a partial defect in centrosomal Aurora A. This defect is normally tolerated but, when exacerbated by pharmacological Aurora A inhibition, causes metaphase arrest and mitotic cell death. Restoring centrosomal Aurora A, or inhibiting ROCK, abolishes this effect. Low tumoral Aurora A is present in most primary lobular tumors. These findings refine the view that high Aurora A expression predicts inhibitor sensitivity and provide the preclinical rationale for trials in mILC.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2026-11-21
DOI
https://doi.org/10.1016/j.celrep.2026.118366
Primary Topic
Microtubule and mitosis dynamics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

E-cadherin/Aurora A kinase inhibitor synthetic lethality in breast cancer

Queenie T. K. Lai, Asha Konde, Naomi Guppy, Jyoti Sharma Choudhary et al.
Cell Reports
Microtubule and mitosis dynamics
article

E-cadherin/Aurora A kinase inhibitor synthetic lethality in breast cancer

Queenie T. K. Lai, Asha Konde, Naomi Guppy, Jyoti Sharma Choudhary, Anya A Nicholas, Rachel Brough, Ross Scrimgeour, Clare M. Isacke, Feifei Song, Amanda Fitzpatrick, Cathrin Brisken, Theodoros I. Roumeliotis, Kai B. Betteridge, Renée L. Flaherty, Stephen J. Pettitt, Andrew N.J. Tutt, Christopher J. Lord, William W. Yang, Chris Starling, Ioannis Roxanis, Solene Pezot, Sarah Meehan
article en

Abstract

Invasive lobular breast carcinoma (ILC) is defined by loss of the adhesion protein E-cadherin. Using a cancer histology-focused analysis of large-scale drug sensitivity screens, we identify inhibition of the kinase Aurora A as a penetrant synthetic lethal interaction with E-cadherin loss. Combining isogenic cell models, quantitative proteomics, live-cell imaging, patient-derived tumor organoids, and orthotopic xenografts from patients with heavily pre-treated metastatic ILC (mILC), we show that E-cadherin loss alters catenin/Rho/ROCK signaling and imposes a partial defect in centrosomal Aurora A. This defect is normally tolerated but, when exacerbated by pharmacological Aurora A inhibition, causes metaphase arrest and mitotic cell death. Restoring centrosomal Aurora A, or inhibiting ROCK, abolishes this effect. Low tumoral Aurora A is present in most primary lobular tumors. These findings refine the view that high Aurora A expression predicts inhibitor sensitivity and provide the preclinical rationale for trials in mILC.

Cell ReportsVol. 45(12)
Institute of Cancer Research (GB), City, University of London (GB), King's College London (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Breast Cancer Now (GB), City St George's, University of London (GB), École Polytechnique Fédérale de Lausanne (CH)
Microtubule and mitosis dynamics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon